Teva (TEVA +0.25%) and Active Biotech (ATVBF.PK) say that early treatment of Multiple Sclerosis...

Teva (TEVA +0.25%) and Active Biotech (ATVBF.PK) say that early treatment of Multiple Sclerosis with their Laquinimod drug significantly cuts the risk of disability progression in patients, a Phase III trial shows. Additional data from an animal preclinical study demonstrates that laquinimod can restore myelination in the brain and spinal cord. (PR)

From other sites
Comments (3)
  • doc47
    , contributor
    Comments (1713) | Send Message
    Typical Teva stock behavior: good news it goes up a few cents, bad news it's down a couple bucks. When is this going to change?
    21 Mar 2013, 09:42 AM Reply Like
  • Michael Bryant
    , contributor
    Comments (6911) | Send Message
    (TEVA) is an Israeli company, and Israel is in a tough time now with Syria, Iran, and maybe Egypt.
    21 Mar 2013, 01:09 PM Reply Like
  • catbird
    , contributor
    Comments (117) | Send Message
    Recent news to add to Pharma pipeline have lifted TEVA to 40 level. Helping others in distress to have a better quality of life. That's so important. Once recognized, we stockholders should benefit too.
    21 Mar 2013, 04:24 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs